Corcept Therapeutics Incorporated (NASDAQ:CORT) Q2 2024 Earnings Call Transcript July 29, 2024
Corcept Therapeutics Incorporated beats earnings expectations. Reported EPS is $0.32, expectations were $0.23.
Operator: Hello. Thank you for standing by. Welcome to Corcept Therapeutics’ Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions] I would now like to turn the...
